Trials / Withdrawn
WithdrawnNCT01758705
Post Marketing Observational Study on Venezuelan Patients With Psoriasis
Observational Study; Clinical Effectiveness and Impact on Patient Reported Outcomes in Venezuelan Patients With Psoriasis After 16 Weeks of ADA Therapy
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- AbbVie (prior sponsor, Abbott) · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to obtain Venezuelan data of clinical effectiveness, impact in the HRQoL, work productivity and activity impairment in patients with psoriasis using adalimumab.
Conditions
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2013-01-01
- Last updated
- 2016-11-29
Source: ClinicalTrials.gov record NCT01758705. Inclusion in this directory is not an endorsement.